Mr. Cohen had been serving as MediWound’s CEO since November 2006. Prior to joining MediWound, Mr. Cohen held several management positions at Teva Pharmaceutical Industries Ltd. as Director of Strategic Business Planning & New Ventures, Projects Manager for the Global Products Division and Team Leader at Teva’s Corporate Industrial engineering department. During this period, he led various business transactions and alliances with start-up companies and academic institutions, was the Project Manager of the launch of Copaxone®, Teva’s flagship innovative product, in numerous countries as well as for the development of various medical devices. Mr. Cohen holds a cum laude B.Sc. in Industrial Engineering & Management from the Technion -Israel’s Institute of Technology and a cum laude MBA from Tel-Aviv University.